Home » Topics » BioWorld Science

BioWorld Science
RSS

Advanced Proteome Therapeutics reports preclinical finding on antibody-amanitin conjugate

Oct. 10, 2018

Biohaven licenses therapeutic antibody from University of Connecticut

Oct. 10, 2018

Wave Life Sciences to design products for rare inherited eye diseases

Oct. 10, 2018

Newly developed IgA nephropathy murine model shows autoimmune character

Oct. 10, 2018

Neurocrine Biosciences and Jnana collaborate to treat CNS disorders

Oct. 10, 2018

First-in-human data presented for branaplam in SMA type 1

Oct. 10, 2018

Acceleron presents preliminary phase II data for ACE-083 in patients with CMT

Oct. 10, 2018

Forskolin-induced swelling of intestinal organoids classifies cystic fibrosis disease severity

Oct. 10, 2018

Cancer drugs may be repurposed for inflammation

Oct. 10, 2018

AgeneBio obtains grants to support phase III study of AGB-101

Oct. 10, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists
BioWorld Science
Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.